Alerts will be sent to your verified email
Verify Email
BALPHARMA
|
Bal Pharma
|
Wintac
|
Aimco Pesticide
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
1.02 % | 13.12 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
0.96 % | 78.06 % | 12.14 % |
|
5yr average Equity Multiplier
|
4.45 | -4.32 | 3.36 |
|
5yr Average Asset Turnover Ratio
|
0.94 | 0.65 | 1.51 |
|
5yr Avg Net Profit Margin
|
-0.14 % | -8.7 % | 2.21 % |
|
Price to Book
|
2.5 | 0.0 | 2.4 |
|
P/E
|
45.0 | 193.85 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
39.08 Days | -191.8 Days | -16.79 Days |
|
Inventory Days
|
108.27 Days | 77.6 Days | 102.98 Days |
|
Days Receivable
|
101.56 Days | 24.76 Days | 58.0 Days |
|
Days Payable
|
117.24 Days | 266.89 Days | 146.91 Days |
|
5yr Average Interest Coverage Ratio
|
1.1 | -2.44 | 7.32 |
|
5yr Avg ROCE
|
13.66 % | 22.62 % | 18.41 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 0.23 % | 5.48 % |
|
5 yr average Debt to Equity
|
2.0 | -2.95 | 0.15 |
|
5yr CAGR Net Profit
|
-7.48 % | n/a | n/a |
|
5yr Average Return on Assets
|
0.26 % | -5.26 % | 3.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.23 % | 54.99 % | 53.5 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
6.25 % | 0.0 | 2.15 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bal Pharma
|
Wintac
|
Aimco Pesticide
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
